Gliosarcoma
📧 Sign up to get email alerts when something new happens for Gliosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 1, Phase 2]
Clinical trial update for tandutinib in recurrent or progressive glioblastoma (Phase 1/2) reports completion with results posted in 2017. Th…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating bi-weekly temozolomide plus bevacizumab in adults with recurrent glioblastoma multiforme and recurrent gliosarcom…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Pazopanib in Treating Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial update of pazopanib for recurrent glioblastoma; results have been posted following study completion.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy in combination with sargramostim (GM-CSF) for malignant glioma, including several glioma…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors [Phase 2]
Phase 2 trial evaluating bevacizumab with or without trebananib for recurrent brain tumors has completed enrollment with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors [Phase 1]
Phase 1 clinical trial evaluating aminolevulinic acid during surgery for malignant brain tumors; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas [Phase 2]
Phase 2 clinical trial evaluating radiation therapy with temozolomide and lomustine in young patients with newly diagnosed gliomas; complete…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: FR901228 in Treating Patients With Recurrent High-Grade Gliomas [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated FR901228 in adults with recurrent high-grade gliomas; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma [Phase 3]
Phase 3 trial evaluating temozolomide with radiation therapy with or without bevacizumab in newly diagnosed glioblastoma; study completed wi…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]
A phase 2 clinical trial evaluated temozolomide plus radiation with or without cediranib maleate in newly diagnosed glioblastoma and gliosar…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery [Phase 1]
This clinical trial update reports on a Phase 1 study of the oncolytic herpes simplex virus HSV-1716 in children with refractory or recurren…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial update of erlotinib and sorafenib in progressive or recurrent glioblastoma multiforme; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]
Clinical trial update for Temsirolimus and Perifosine in recurrent or progressive malignant glioma (Phase 1/2) with completed status and pos…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas [Phase 2]
Results from a Phase II randomized trial in adults with recurrent high-grade gliomas comparing vandetanib with carboplatin followed by vande…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Sunitinib in Treating Patients With Recurrent Malignant Gliomas [Phase 2]
Phase 2 trial evaluating sunitinib for adults with recurrent malignant gliomas has completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
ClinicalTrials.gov indicates a completed Phase 1/2 study evaluating cilengitide with temozolomide and radiation for newly diagnosed glioblas…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating suppression of the PI3K/Akt pathway in glioblastoma and gliosarcoma, compared with pembrolizumab (MK-347…
-
CLINICAL_TRIALS withdrawal · 2016-02-15Clinical Trial Update: EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating EGFRBi-armed autologous T cells for adult brain glioblastoma and gliosarcoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: AMG 102 and Avastin for Recurrent Malignant Glioma [Phase 2]
Phase 2 trial results for AMG 102 in combination with Avastin (bevacizumab) for recurrent malignant glioma have been posted. The study inclu…
-
CLINICAL_TRIALS withdrawal · 2015-11-06Clinical Trial Update: Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 2]
A Phase II trial evaluating sorafenib with radiation and temozolomide for newly diagnosed glioblastoma or gliosarcoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide [Phase 2]
Phase 2 trial evaluating aflibercept (VEGF Trap) for recurrent malignant gliomas unresponsive to temozolomide has completed; results were po…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) [Phase 1]
A Phase 1 safety study of ridaforolimus (AP23573) in patients with progressive or recurrent glioma has completed, including glioblastoma and…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma [Phase 1, Phase 2]
Phase 1/2 trial evaluating RO4929097 in combination with Bevacizumab for progressive or recurrent malignant glioma was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 trial update for PSMA-targeted approach in glioblastoma multiforme (GBM) showing completed results as of 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-15Clinical Trial Update: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma [Phase 1, Phase 2]
This entry reports the completion and posted results of a Phase 1/2 trial evaluating erlotinib in combination with temsirolimus for recurren…